Alerts will be sent to your verified email
Verify EmailSOLARA
Solara Active Pharma
|
IOL Chem & Pharma
|
Morepen Laboratories
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Manufacturing Capacity - Ibuprofen
|
5000.0 MTPA | 12000.0 MTPA | n/a |
US DMF Filings
|
230.0 . | n/a | n/a |
Financials
|
|||
5 yr Average ROE
|
-8.31 % | 8.9 % | 13.75 % |
5yr average Equity Multiplier
|
1.98 | 1.42 | 1.84 |
5yr Average Asset Turnover Ratio
|
0.55 | 0.99 | 1.34 |
5yr Avg Net Profit Margin
|
-5.56 % | 6.28 % | 5.42 % |
Price to Book
|
2.67 | 1.74 | 2.74 |
P/E
|
119.02 | 29.13 | 26.82 |
5yr Avg Cash Conversion Cycle
|
115.03 Days | 37.81 Days | 21.38 Days |
Inventory Days
|
106.31 Days | 65.55 Days | 53.55 Days |
Days Receivable
|
125.38 Days | 86.45 Days | 63.5 Days |
Days Payable
|
142.19 Days | 100.1 Days | 98.41 Days |
5yr Average Interest Coverage Ratio
|
0.55 | 15.8 | 39.33 |
5yr Avg ROCE
|
3.01 % | 12.63 % | 15.84 % |
5yr Avg Operating Profit Margin
|
10.34 % | 10.64 % | 8.37 % |
5 yr average Debt to Equity
|
0.69 | 0.04 | 0.04 |
5yr CAGR Net Profit
|
n/a | -9.63 % | 23.42 % |
5yr Average Return on Assets
|
-2.61 % | 6.27 % | 7.36 % |
Shareholdings
|
|||
Promoter Holding
|
42.01 % | 52.62 % | 35.65 % |
Share Pledged by Promoters
|
38.95 % | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
1.61 % | 8.93 % | -1.09 % |
Change in Mutual Fund Holding (3 Yrs)
|
-1.56 % | 0.0 | 0.0 |
Solara Active Pharma
|
IOL Chem & Pharma
|
Morepen Laboratories
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|